ARTMS Inc. completes acquisition of Telix Pharmaceuticals Limited to strengthen medical isotope production
Acquiring Company
ARTMS
Acquired Company
Telix Pharmaceuticals Limited
Burnaby
MelbourneManufacturingBiotechnologyMedical DeviceBiotechnologyDescription
ARTMS Inc. is pleased to announce the successful acquisition of Telix Pharmaceuticals Limited. This acquisition is set to enhance the supply chain and regulatory control of producing key isotopes at ARTMS, further strengthening its vertical integration in the manufacturing space. The acquisition will enable ARTMS to efficiently and cost-effectively support the large-scale production of medical isotopes and collaborate with other radiopharmaceutical companies to ensure the availability of these critical isotopes to patients. Additionally, ARTMS’s advanced cyclotron technology will facilitate Telix's production of future important commercial alpha-emitting therapeutic isotopes including radium-225 (225Ac) and astatine-211 (211At), allowing for immediate commercial use.
Quick answer
ARTMS is acquiring Telix Pharmaceuticals Limited, announced April 12, 2024. ARTMS is based in Burnaby, British Columbia, Canada.
- How much did ARTMS pay for Telix Pharmaceuticals Limited?
- The deal value was not disclosed.
- What does ARTMS do?
- ARTMS Inc. is a privately held, venture-backed company based in Burnaby, BC, Canada.
- Where are ARTMS and Telix Pharmaceuticals Limited based?
- ARTMS is based in Burnaby, British Columbia, Canada. Telix Pharmaceuticals Limited is based in Melbourne, Victoria, Australia.
- Who are the decision-makers at ARTMS?
- Fundz holds 2 contacts at ARTMS. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical Device and Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Wytech Industries and Mountain Manufacturing Technologies acquire Silvertip & Associates to strengthen precision grinding capabilities (April 3, 2024)
- Healthcare Holding Schweiz AG completes acquisition of MCM Medsys AG to expand its product portfolio (April 25, 2024)
- IMCD Spain acquires Cobapharma, S.L.U to strengthen its Pharmaceuticals presence (April 24, 2024)
- Eli Lilly and Company acquires manufacturing facility from Nexus Pharmaceuticals to expand U.S. capacity (April 22, 2024)
- CoreRx, Inc. completes acquisition of Societal CDMO, Inc. to enhance drug formulation and manufacturing capabilities (April 8, 2024)
- Shimadzu Medical Systems USA completes acquisition of California X-ray Imaging Services, Inc. to strengthen Healthcare Business (April 6, 2024)
Who to call at ARTMS, and when
When ARTMS changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day ARTMS raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ARTMS, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ARTMS. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ARTMS makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Telix Pharmaceuticals Limited?
Telix Pharmaceuticals Limited was acquired by ARTMS, based in Burnaby. The deal was reported on April 12, 2024. ARTMS Inc. is a privately held, venture-backed company based in Burnaby, BC, Canada. The company specializes in the physics, chemistry, and materials science of cyclotron-produced radionuclides. ARTMS is privately held and operates in Manufacturing.
When did ARTMS acquire Telix Pharmaceuticals Limited?
ARTMS's acquisition of Telix Pharmaceuticals Limited was reported on April 12, 2024. ARTMS Inc. is pleased to announce the successful acquisition of Telix Pharmaceuticals Limited. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Telix Pharmaceuticals Limited do?
Telix Pharmaceuticals Limited (ASX: TLX) is a leading pharmaceutical company specializing in advanced diagnostic and therapeutic radiopharmaceuticals. It is publicly traded (TLX), operating in Biotechnology, and is based in Melbourne.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.